A generative AI SaaS platform for de novo drug design.

Tool: Makya
Description: A generative AI SaaS platform for de novo drug design.
Summary: Makya is a generative AI platform tailored for chemists, focusing on the creation of diverse, novel, and medchem-like molecules that are synthetically accessible and optimized for success. It incorporates a unique chemistry-driven approach, ensuring each molecule is designed with synthetic accessibility and multi-parametric optimization in mind, including the inclusion of 3D constraints.
Category: Drug Discovery
Tags: Drug Discovery
Use Cases: Designing novel molecules with a focus on synthetic accessibility for drug discovery projects.; Optimizing molecules with multi-parametric considerations including 3D constraints.
Platform: Web
Vendor: Iktos
Target Users: Researcher
Pricing: subscription
Regulatory: not a medical device
Meta: Makya by Iktos is a generative AI platform for chemists, optimizing drug design with a focus on synthetic accessibility and multi-parametric optimization.
Content: [![](https://images.prismic.io/iktos/Zl9zKZm069VX1dXi_iktos-2-white-2.png?auto=compress,format)\\ \\ ![](https://images.prismic.io/iktos/Zl9y7Jm069VX1dXW_iktos-2-black.png?auto=compress,format)](https://iktos.ai/) Solutions Generative AI ![Generative AI](https://images.prismic.io/iktos/ZqkJph5LeNNTxmj2_Group45886.png?auto=compress,format) Makya, the first generative AI platform designed by chemists for chemists. [Discover](https://iktos.ai/solution/makya) AI-Driven Retrosynthesis ![AI-Driven Retrosynthesis](https://images.prismic.io/iktos/ZqkJ4B5LeNNTxmkI_Group45888.png?auto=compress,format) Spaya is our cutting-edge AI-driven retrosynthesis platform. [Discover](https://iktos.ai/solution/spaya) Discovery Collaboration ![Discovery Collaboration](https://images.prismic.io/iktos/ZmxSVJm069VX1w1R_iktos-placeholder.png?auto=compress,format) Accelerate the development of new drug candidates. [Discover](https://iktos.ai/collaborations) [Discovery platform](https://iktos.ai/discovery-platform) [Pipeline](https://iktos.ai/pipeline) [About us](https://iktos.ai/about) Resources Latest News ![Latest News](https://images.prismic.io/iktos/ZmxSVJm069VX1w1R_iktos-placeholder.png?auto=compress,format) Stay informed with the most recent updates and developments from Iktos. [Discover](https://iktos.ai/resources/articles) Our Resources ![Our Resources](https://images.prismic.io/iktos/Zn9R6h5LeNNTwpAQ_resources.png?auto=compress,format) Browse our extensive collection of publications, webinars, and factsheets. [Discover](https://iktos.ai/resources/medias) Network Stay updated with Iktos [Careers](https://iktos.ai/careers) [Contact Us](https://iktos.ai/contact) Drug Discovery as it will be # Pioneering AI and Robotics in Drug Discovery Iktos leverages cutting-edge AI and robotics to transform drug discovery. By integrating the creativity of Generative AI with automated synthesis and testing, we are forging a path towards fully autonomous labs, accelerating the development of new treatments to improve patient care. Follow a molecule’s journey through Iktos’s platform, from inception to drug candidate, iterating through the DMTA cycle. ## Embark on the Molecular Odyssey The journey begins with Makya's AI-driven design, continues with Spaya's efficient retrosynthesis, and advances through Iktos Robotics for synthesis, purification, analysis, and testing. This integrated approach shortens the discovery phase to under 2 years. Innovative molecular Design Generative AI Makya Makya, our generative AI SaaS platform, starts the molecular journey by creating diverse, novel, and medchem-like molecules. With its unique chemistry driven approach, it ensures each molecule is synthetically accessible and optimized for success. **Key Features** - Generative AI technology for de novo drug design - Focus on synthetic accessibility - Multi-parametric optimization - Inclusion of 3D constraints Efficient Synthesis Planning Retrosynthesis AI Spaya The next step in the journey involves Spay

Makya by Iktos is a generative AI platform for chemists, optimizing drug design with a focus on synthetic accessibility and multi-parametric optimization.

Makya

Makya is a generative AI platform tailored for chemists, focusing on the creation of diverse, novel, and medchem-like molecules that are synthetically accessible and optimized for success. It incorporates a unique chemistry-driven approach, ensuring each molecule is designed with synthetic accessibility and multi-parametric optimization in mind, including the inclusion of 3D constraints.

Makya

Categories

Description

Summary

Use Cases

Platforms

Regulatory Status

API Available

Added to Directory

Target Customer

Contact